 BEDFORD, Mass.--BUSINESS WIRE--Stoke Therapeutics, Inc., Nasdaq: STOK, a biotechnology company dedicated to addressing the underlying cause of severe diseases by up-regulating protein expression with RNA-based medicines, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at two upcoming investor conferences, which will each be conducted in a fireside chat format: Stifel 3rd Annual CNS Day Date: Wednesday, March 31, 2021 Time: 2:00 p.m. ET 20th Annual Needham Vir 